A smoke-free home intervention in permanent supportive housing for formerly homeless adults

Duration
60 Minutes
Speakers

Maya Vijayaraghavan, MD, MAS

Director, Smoking Cessation Leadership Center, University of California, San Francisco, Steven A. Schroeder Distinguished Professor of Health and Health Care, Professor of Medicine

Dr. Vijayaraghavan is a practicing general internist and a researcher in tobacco control with a focus on populations experiencing homelessness. She is the Director of the UCSF Smoking Cessation Leadership Center, a Center focused on eliminating disparities in tobacco use prevalence among behavioral health populations. Through her work, funded by the NIH and the Tobacco Related Disease Research Program, she has intervened at the individual, community, health systems, and policy levels to increase access to tobacco treatment and tobacco-free policies. She has collaborated with homeless shelters and supportive housing to implement interventions to increase access to smoking cessation services and smoke-free policies for people who have experienced homelessness with co-occurring mental health and substance us disorders. She co-directs a NIDA-funded postdoctoral training program at the Center for Tobacco Control Research and Education, focused on tobacco and substance use related research. She practices primary care at the San Francisco General Hospital.

Webinar Objectives

1.Describe two ways that tobacco use impacts homeless adults

2.Discuss all of the results of a pilot study of a smoke-free home intervention in supportive housing

3.Discuss one other promising strategy to engage with people experiencing homelessness around smoking cessation

Instructions for CME/CE Credit

CME/CEU credit is no longer available for the recorded version of the webinar. The accreditation has expired for this course.

 

Certificates of Attendance

 

Click here to generate a certificate of attendance for participating on this webinar.

 

Additional Resources Cited in the Webinar
  • Here are resources used by Dr. Vijayaraghavan in her pilot study: